Home › Drug manufacturer agrees to $500 million penalty
 

Keywords :   


Drug manufacturer agrees to $500 million penalty

2013-05-14 06:31:11| Biotech - Topix.net

A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S. Federal prosecutors say the guilty plea by Ranbaxy USA Inc.

Tags: million drug manufacturer penalty

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Nebraska celebrates new feedlot research, teaching, extension center
03.07Hurricane Beryl Public Advisory Number 20A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07Atlantic Tropical Weather Outlook
03.07Genesus to restructure with Canada ZF Investments
03.07Global trade, domestic policy: What's at stake for pork industry
03.07Over 20,000 Tesco staff to split 30m from share schemes
More »